Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Joshua R. K. Yoneda"'
Autor:
Dakota J. S. J. Peacock, Joshua R. K. Yoneda, Jodi E. Siever, Mathew Vis-Dunbar, Cyrus Boelman
Publikováno v:
Journal of child neurology. 37(6)
Novel antiseizure medications are thought to be safer than their conventional counterparts, though no dedicated analysis of movement disorder risk among pediatric populations using novel antiseizure medications has been completed. We report a systema
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a585b6726467b670df50860fb2302cf5
https://pubmed.ncbi.nlm.nih.gov/35392704
https://pubmed.ncbi.nlm.nih.gov/35392704
Autor:
Stefani C. Kary, Andrew D. S. Cameron, Stephen C. Olshefsky, Joshua R. K. Yoneda, Steven B. West, Laura A. Stewart
Publikováno v:
Antimicrobial Agents and Chemotherapy. 61
Fluoroquinolone antibiotics are prescribed for the treatment of Salmonella enterica infections, but resistance to this family of antibiotics is growing. Here we report that loss of the global regulatory protein cyclic AMP (cAMP) receptor protein (CRP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::441c0147709ebd6163cfb79b71432c0a
https://doi.org/10.1128/aac.01666-17
https://doi.org/10.1128/aac.01666-17
Autor:
David C. Alexander, Supriya V. Bhat, Teagan Oleksyn, Cameron Andrew, Joshua R. K. Yoneda, Jeffrey M. Chen
Publikováno v:
Open Forum Infectious Diseases
Background Bedaquiline (BDQ) is an FDA approved antibiotic with antimycobacterial activity. BDQ resistance has been observed in several Mycobacterium species. High-level resistance is due to mutations in ATP synthase. Low -level resistance is attribu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea74df0cfdcc3ee01823b270fc045ce2
https://doi.org/10.1093/ofid/ofz359.090
https://doi.org/10.1093/ofid/ofz359.090